GNBT | Generex Biotech Gets A Bounce In Its Step Finally

gnbtAt the end of 2012, we updated our coverage on the penny stock of Generex Biotechnology Corp. (GNBT) and the devastating slide the shares had been on all year. With hopes and expectations that someone would come along and drop some much needed cash into the biotech focused on treating and curing breast cancer, the news of an investor conference call scheduled for 10am today was enough ...

Continue Reading →
0

GNBT | Generex Biotechnology Stock Still Getting Buried

gnbtWhile 2012 has been a banner year for a number of biotech stocks and their shareholders, one company which was not as fortunate has traders studying them in hopes they may have finally reached the oversold level. The year started out great for Generex Biotechnology Corp. (GNBT) with their proprietary technology to ward of tumors in breast cancer patients gaining rave reviews. However, since the shares ...

Continue Reading →
0